The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global healthcare cold chain logistics market was valued at US$ 16.5 Billion in 2021.
We expect the global healthcare cold chain logistics market to exhibit a CAGR of 3.4% during 2022-2027.
The increasing outsourcing preferences in the pharmaceutical and biopharmaceutical sector for drugs, vaccines and clinical trial materials, represents one of the factors driving the global healthcare cold chain logistics market.
Sudden outbreak of the COVID-19 pandemic has led to the increasing utilization for healthcare cold chain logistics for storing and transporting vaccines across the globe.
Based on the product, the global healthcare cold chain logistics market has been segmented into vaccines, clinical trials, and biopharmaceuticals. Currently, vaccines hold the majority of the total market share.
Based on the segment, the global healthcare cold chain logistics market can be segregated into transportation, packaging, and instrumentation. Among these, the packaging sector currently represents the largest segment.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe and Rest of the World, where Asia-Pacific currently dominates the global market.
Some of the major players in the global healthcare cold chain logistics market include Amerisource Bergen Corporation (World Courier), Deutsche Post AG (DHL), FedEx Corporation Services, Inc., United Parcel Service of America, Inc., Kuehne + Nagel International AG, Cavalier Logistics, Inc., DB Schenker, Life ConEx, American Airlines Cargo, Continental Air Cargo and Marken.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at